Cargando…
PLA1A expression as a diagnostic marker of BRAF-mutant metastasis in melanoma cancer
BRAF and NRAS are the most reported mutations associated to melanomagenesis. The lack of accurate diagnostic markers in response to therapeutic treatment in BRAF/NRAS-driven melanomagenesis is one of the main challenges in melanoma personalized therapy. In order to assess the diagnostic value of pho...
Autores principales: | Yang, Gang, Liu, Shuya, Maghsoudloo, Mazaher, Shasaltaneh, Marzieh Dehghan, Kaboli, Parham Jabbarzadeh, Zhang, Cuiwei, Deng, Youcai, Heidari, Hajar, Entezari, Maliheh, Fu, ShaoZhi, Wen, QingLian, Imani, Saber |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961027/ https://www.ncbi.nlm.nih.gov/pubmed/33723350 http://dx.doi.org/10.1038/s41598-021-85595-7 |
Ejemplares similares
-
Comparative mRNA/micro-RNA co-expression network drives melanomagenesis by promoting epithelial–mesenchymal transition and vasculogenic mimicry signaling
por: He, WenFeng, et al.
Publicado: (2021) -
Genome-wide copy number analysis of circulating tumor cells in breast cancer patients with liver metastasis
por: Zou, Linglin, et al.
Publicado: (2020) -
Treatment of malignant pleural effusion in non-small cell lung cancer with VEGF-directed therapy
por: Xiang, Zhangqiang, et al.
Publicado: (2022) -
Descriptive statistics of dataset from the meta-analysis and meta-regression analysis on prognostic significance of pre-treatment systemic hemato-immunological indices of cervical cancer patients
por: Han, Xingping, et al.
Publicado: (2021) -
Dermokine mutations contribute to epithelial-mesenchymal transition and advanced melanoma through ERK/MAPK pathways
por: Ma, Wenqiong, et al.
Publicado: (2023)